Trump: Lower cost deals made with 9 drugmakers | Northwest Arkansas Democrat-Gazette

Contributing sentiments towards policy:

61% : Known as Eliquis, it is the company's top prescribed drug as well as being one of Medicaid's most widely-used medicines.
57% : As part of the deal, new drugs made by those companies will also be charged at the "most-favored-nation" pricing across the country on any newly launched medications for all, including commercial and cash pay markets as well as Medicare and Medicaid.
51% : Patients in Medicaid, the state and federally funded program for people with low incomes, already pay a nominal co-payment of a few dollars to fill their prescriptions, but lower prices could help state budgets that fund the programs.
51% : William Padula, a pharmaceutical and health economics professor at the University of South California's Alfred E. Mann School of Pharmacy and Pharmaceutical Studies, said Medicaid already has the most favorable drug rates -- which in some cases will be close to what the "most-favored-nation" price is -- so it remains to be seen what other impacts it could have, such as more research and development.
49% : The New Jersey-based Bristol Myers Squibb further announced that it will be giving for free to the Medicaid program its signature blood thinner prescribed to reduce the risk of blood clots and stroke.
47% : President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now rein in Medicaid drug prices to match what they charge in other developed countries.
41% : Most people have coverage through work, the individual insurance market or government programs like Medicaid and Medicare, which shield them from much of the cost.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.